- Home
- DWTX vs DGLY Comparison
DWTX vs DGLY Comparison
Compare DWTX & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DWTX
- DGLY
- Stock Information
- Founded
- DWTX 2012
- DGLY 2004
- Country
- DWTX United States
- DGLY United States
- Employees
- DWTX N/A
- DGLY N/A
- Industry
- DWTX
- DGLY Radio And Television Broadcasting And Communications Equipment
- Sector
- DWTX
- DGLY Technology
- Exchange
- DWTX NYSE
- DGLY Nasdaq
- Market Cap
- DWTX 4.0M
- DGLY 3.8M
- IPO Year
- DWTX N/A
- DGLY N/A
- Fundamental
- Price
- DWTX $2.52
- DGLY $0.85
- Analyst Decision
- DWTX
- DGLY
- Analyst Count
- DWTX 0
- DGLY 0
- Target Price
- DWTX N/A
- DGLY N/A
- AVG Volume (30 Days)
- DWTX 80.6K
- DGLY 411.6K
- Earning Date
- DWTX 11-07-2024
- DGLY 11-29-2024
- Dividend Yield
- DWTX N/A
- DGLY N/A
- EPS Growth
- DWTX N/A
- DGLY N/A
- EPS
- DWTX N/A
- DGLY N/A
- Revenue
- DWTX N/A
- DGLY $23,417,110.00
- Revenue This Year
- DWTX N/A
- DGLY $22.14
- Revenue Next Year
- DWTX N/A
- DGLY N/A
- P/E Ratio
- DWTX N/A
- DGLY N/A
- Revenue Growth
- DWTX N/A
- DGLY N/A
- 52 Week Low
- DWTX $1.62
- DGLY $0.56
- 52 Week High
- DWTX $23.50
- DGLY $3.29
- Technical
- Relative Strength Index (RSI)
- DWTX N/A
- DGLY 49.76
- Support Level
- DWTX N/A
- DGLY $1.01
- Resistance Level
- DWTX N/A
- DGLY $0.87
- Average True Range (ATR)
- DWTX 0.00
- DGLY 0.14
- MACD
- DWTX 0.00
- DGLY 0.01
- Stochastic Oscillator
- DWTX 0.00
- DGLY 47.62
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.